| Primary |
| Abortion Induced |
24.5% |
| Abortion |
15.8% |
| Labour Induction |
15.8% |
| Induced Labour |
7.9% |
| Off Label Use |
4.1% |
| Prophylaxis Against Gastrointestinal Ulcer |
3.8% |
| Back Pain |
3.3% |
| Duodenal Ulcer |
2.4% |
| Gastric Ulcer |
2.4% |
| Osteoporosis |
2.4% |
| Abortion Spontaneous |
2.2% |
| Dyspepsia |
1.9% |
| Postpartum Haemorrhage |
1.9% |
| Surgery |
1.9% |
| Angina Pectoris |
1.6% |
| Gastritis |
1.6% |
| Ill-defined Disorder |
1.6% |
| Peptic Ulcer |
1.6% |
| Pharyngitis |
1.6% |
| Procedural Pain |
1.6% |
|
| Off Label Use |
33.5% |
| Drug Ineffective For Unapproved Indication |
10.5% |
| Uterine Rupture |
7.7% |
| Vaginal Haemorrhage |
6.7% |
| Vomiting |
6.7% |
| Tremor |
4.8% |
| Pyrexia |
3.8% |
| Stevens-johnson Syndrome |
2.9% |
| Drug Exposure During Pregnancy |
2.4% |
| Haemorrhage |
2.4% |
| Pallor |
2.4% |
| Palpitations |
2.4% |
| Hepatitis Fulminant |
1.9% |
| Overdose |
1.9% |
| Renal Failure |
1.9% |
| Tachycardia |
1.9% |
| Uterine Haemorrhage |
1.9% |
| Granulocytopenia |
1.4% |
| Maternal Exposure During Pregnancy |
1.4% |
| Medication Error |
1.4% |
|
| Secondary |
| Rheumatoid Arthritis |
26.3% |
| Drug Use For Unknown Indication |
9.7% |
| Product Used For Unknown Indication |
8.8% |
| Osteoporosis |
5.1% |
| Duodenal Ulcer |
4.8% |
| Nasopharyngitis |
4.8% |
| Abortion Induced |
4.2% |
| Peptic Ulcer |
4.2% |
| Gastric Disorder |
3.5% |
| Gastritis |
3.5% |
| Hypertension |
3.2% |
| Spinal Compression Fracture |
3.2% |
| Postpartum Haemorrhage |
3.0% |
| Pain |
2.8% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.8% |
| Off Label Use |
2.3% |
| Multiple Allergies |
2.1% |
| Pharyngitis |
2.1% |
| Constipation |
1.8% |
| Pyrexia |
1.8% |
|
| Pyrexia |
12.4% |
| Off Label Use |
9.5% |
| Bone Fissure |
6.7% |
| Drug Ineffective For Unapproved Indication |
6.7% |
| Pancytopenia |
6.7% |
| Vomiting |
6.7% |
| Interstitial Lung Disease |
5.7% |
| Anaemia |
4.8% |
| Postpartum Haemorrhage |
4.8% |
| Hepatic Function Abnormal |
3.8% |
| Oedema |
3.8% |
| Renal Failure |
3.8% |
| Toxic Epidermal Necrolysis |
3.8% |
| Tremor |
3.8% |
| Drug Exposure During Pregnancy |
2.9% |
| Multiple Myeloma |
2.9% |
| Nephrolithiasis |
2.9% |
| Rectal Perforation |
2.9% |
| Small Intestinal Resection |
2.9% |
| Tuberculosis |
2.9% |
|
| Concomitant |
| Rheumatoid Arthritis |
36.3% |
| Prophylaxis |
11.4% |
| Product Used For Unknown Indication |
9.1% |
| Drug Use For Unknown Indication |
7.4% |
| Hypertension |
5.2% |
| Pain |
4.3% |
| Osteoporosis |
3.5% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.7% |
| Constipation |
2.6% |
| Cancer Pain |
2.6% |
| Renal Cell Carcinoma |
2.2% |
| Gastritis |
1.9% |
| Insomnia |
1.9% |
| Gastritis Prophylaxis |
1.5% |
| Antibiotic Prophylaxis |
1.5% |
| Gastric Ulcer |
1.5% |
| Metastatic Renal Cell Carcinoma |
1.3% |
| Hyperlipidaemia |
1.1% |
| Lung Adenocarcinoma |
1.1% |
| Non-small Cell Lung Cancer |
1.1% |
|
| Vomiting |
10.6% |
| Pyrexia |
9.3% |
| Interstitial Lung Disease |
8.8% |
| Pneumocystis Jiroveci Pneumonia |
8.5% |
| White Blood Cell Count Decreased |
7.7% |
| Pneumonia |
6.4% |
| Rash |
5.8% |
| Weight Decreased |
5.6% |
| Renal Impairment |
3.7% |
| Sepsis |
3.7% |
| Respiratory Failure |
3.4% |
| Stomatitis |
3.4% |
| Renal Failure Acute |
3.2% |
| Rheumatoid Arthritis |
3.2% |
| Malaise |
2.9% |
| Tachycardia |
2.9% |
| Upper Respiratory Tract Inflammation |
2.9% |
| Melaena |
2.7% |
| Tumour Lysis Syndrome |
2.7% |
| Ventricular Septal Defect |
2.7% |
|
| Interacting |
| Intra-uterine Death |
50.0% |
| Labour Induction |
50.0% |
|
| Kidney Transplant Rejection |
100.0% |
|
